Unknown

Dataset Information

0

An isoniazid analogue promotes Mycobacterium tuberculosis-nanoparticle interactions and enhances bacterial killing by macrophages.


ABSTRACT: Nanoenabled drug delivery systems against tuberculosis (TB) are thought to control pathogen replication by targeting antibiotics to infected tissues and phagocytes. However, whether nanoparticle (NP)-based carriers directly interact with Mycobacterium tuberculosis and how such drug delivery systems induce intracellular bacterial killing by macrophages is not defined. In the present study, we demonstrated that a highly hydrophobic citral-derived isoniazid analogue, termed JVA, significantly increases nanoencapsulation and inhibits M. tuberculosis growth by enhancing intracellular drug bioavailability. Importantly, confocal and atomic force microscopy analyses revealed that JVA-NPs associate with both intracellular M. tuberculosis and cell-free bacteria, indicating that NPs directly interact with the bacterium. Taken together, these data reveal a nanotechnology-based strategy that promotes antibiotic targeting into replicating extra- and intracellular mycobacteria, which could actively enhance chemotherapy during active TB.

SUBMITTER: de Faria TJ 

PROVIDER: S-EPMC3346657 | biostudies-literature | 2012 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

An isoniazid analogue promotes Mycobacterium tuberculosis-nanoparticle interactions and enhances bacterial killing by macrophages.

de Faria Tatiany J TJ   Roman Mariane M   de Souza Nicole M NM   De Vecchi Rodrigo R   de Assis João Vitor JV   dos Santos Ana Lúcia Gomes AL   Bechtold Ivan H IH   Winter Nathalie N   Soares Maurilio José MJ   Silva Luciano Paulino LP   De Almeida Mauro V MV   Báfica André A  

Antimicrobial agents and chemotherapy 20120213 5


Nanoenabled drug delivery systems against tuberculosis (TB) are thought to control pathogen replication by targeting antibiotics to infected tissues and phagocytes. However, whether nanoparticle (NP)-based carriers directly interact with Mycobacterium tuberculosis and how such drug delivery systems induce intracellular bacterial killing by macrophages is not defined. In the present study, we demonstrated that a highly hydrophobic citral-derived isoniazid analogue, termed JVA, significantly incre  ...[more]

Similar Datasets

| S-SCDT-10_15252-EMBJ_2023113490 | biostudies-other
| S-EPMC7558018 | biostudies-literature
| S-EPMC10152147 | biostudies-literature
2021-12-15 | GSE165581 | GEO
| S-EPMC5727946 | biostudies-literature
2019-05-31 | GSE129835 | GEO
| S-EPMC2945763 | biostudies-other
| S-EPMC3220711 | biostudies-literature
| S-EPMC5491555 | biostudies-literature
| S-EPMC3688994 | biostudies-literature